Most people who develop breast cancer have no family history of the disease, but we know that’s not always the case. A person’s family history, inheritance, race and ethnicity are all important risk factors that have long been part of our research agenda. Our scientists have been behind major breakthroughs in this area, including discovering the role BRCA1 and BRCA2 play in breast cancer and uncovering the genetic link to more aggressive forms of the disease in women of African descent. The more progress our researchers make, the better doctors are able to predict who is at risk and what can be done to prevent cancer’s onset. READ MORE
Dr. Ambrosone is a Distinguished Professor of Oncology, Chair of the Department of Cancer...
BCRF Investigator Since
2008
Titles and Affiliations Assistant Professor of Medicine, Division of Oncology, School of Medicine Assistant...
2021
Titles and Affiliations Professor of Laboratory Medicine And Pathology Zbigniew and Anna M. Scheller...
2007
Titles and Affiliations Scientific Director, International Center for the Study of Breast Cancer Subtypes...
2022
Susan M. Domchek, MD is the Basser Professor in Oncology at the Perelman School...
Titles and Affiliations Chairwoman, Genomic Medicine Institute, Cleveland Clinic American Cancer Society Clinical Research...
Titles and Affiliations Physician, Medical Oncology, Dana-Farber Cancer Institute Instructor, Medicine, Harvard Medical School...
Titles and Affiliations Professor of Medicine, Genetics, and Pediatrics Director, Stanford Cancer Genetics Clinic...
2005
Titles and Affiliations Chief, Division of Cancer Genetics and Prevention Susan F. Smith Chair...
2001
Titles and Affiliations Professor and Vice Chair for Faculty Development, Department of Epidemiology and...
When you give to BCRF, you're funding critical hours in the lab. More time for research means longer, healthier lives for the ones we love.
Please remember BCRF in your will planning. Learn More
